blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1437140

EP1437140 - ORAL PHARMACEUTICAL FORMULATION CONTAINING ACTIVE CARBON AND USE OF THE SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.02.2010
Database last updated on 06.07.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
Chen, Decai
No. 1 Building, 7 the 12th South Street, Chengdu
Sichuan 610000 / CN
[2009/16]
Former [2004/29]For all designated states
Chen, Decai
No. 1 Building, 7 the 12th South Street, Chengdu
Sichuan 610000 / CN
Inventor(s)01 / see applicant
...
 [2004/29]
Representative(s)Schnabel, Jörg
Habermann, Hruschka & Schnabel
Montgelasstrasse 2
81679 München / DE
[N/P]
Former [2004/29]Schnabel, Jörg, Dr.
Habermann, Hruschka & Schnabel Montgelasstrasse 2
81679 München / DE
Application number, filing date02754173.909.09.2002
[2004/29]
WO2002CN00630
Priority number, dateCNX112884013.09.2001         Original published format: CN 1128840X
[2004/29]
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03022292
Date:20.03.2003
Language:EN
[2003/12]
Type: A1 Application with search report 
No.:EP1437140
Date:14.07.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 20.03.2003 takes the place of the publication of the European patent application.
[2004/29]
Type: B1 Patent specification 
No.:EP1437140
Date:15.04.2009
Language:EN
[2009/16]
Search report(s)International search report - published on:CN20.03.2003
(Supplementary) European search report - dispatched on:EP06.05.2005
ClassificationIPC:A61K33/44, A61P5/16
[2005/25]
CPC:
A61K33/44 (EP,US); A61P19/10 (EP); A61P21/00 (EP);
A61P3/12 (EP); A61P5/14 (EP); A61P5/16 (EP);
A61P9/00 (EP) (-)
Former IPC [2004/29]A61K33/44
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/29]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ORALE PHARMAZEUTISCHE FORMULIERUNG MIT AKTIVKOHLE UND IHRE VERWENDUNG[2004/29]
English:ORAL PHARMACEUTICAL FORMULATION CONTAINING ACTIVE CARBON AND USE OF THE SAME[2004/29]
French:FORMULATION PHARMACEUTIQUE ORALE CONTENANT DU CHARBON ACTIF ET UTILISATION DE CETTE FORMULATION[2004/29]
Entry into regional phase08.04.2004Translation filed 
08.04.2004National basic fee paid 
08.04.2004Search fee paid 
08.04.2004Designation fee(s) paid 
08.04.2004Examination fee paid 
Examination procedure07.04.2003Request for preliminary examination filed
International Preliminary Examining Authority: CN
08.04.2004Amendment by applicant (claims and/or description)
08.04.2004Examination requested  [2004/29]
26.10.2007Despatch of a communication from the examining division (Time limit: M04)
07.02.2008Reply to a communication from the examining division
14.11.2008Communication of intention to grant the patent
02.03.2009Fee for grant paid
02.03.2009Fee for publishing/printing paid
Opposition(s)18.01.2010No opposition filed within time limit [2010/12]
Request for further processing for:08.09.2005Request for further processing filed
08.09.2005Full payment received (date of receipt of payment)
Request granted
21.12.2005Decision despatched
Fees paidRenewal fee
24.09.2004Renewal fee patent year 03
09.09.2005Renewal fee patent year 04
16.07.2006Renewal fee patent year 05
24.07.2007Renewal fee patent year 06
29.08.2008Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT15.04.2009
BE15.04.2009
CY15.04.2009
CZ15.04.2009
DK15.04.2009
EE15.04.2009
FI15.04.2009
NL15.04.2009
SK15.04.2009
BG15.07.2009
SE15.07.2009
GR16.07.2009
IE09.09.2009
LU09.09.2009
PT15.09.2009
CH30.09.2009
LI30.09.2009
MC30.09.2009
[2011/45]
Former [2011/21]AT15.04.2009
BE15.04.2009
CZ15.04.2009
DK15.04.2009
EE15.04.2009
FI15.04.2009
NL15.04.2009
SK15.04.2009
BG15.07.2009
SE15.07.2009
GR16.07.2009
IE09.09.2009
LU09.09.2009
PT15.09.2009
CH30.09.2009
LI30.09.2009
MC30.09.2009
Former [2010/46]AT15.04.2009
BE15.04.2009
CZ15.04.2009
DK15.04.2009
EE15.04.2009
FI15.04.2009
NL15.04.2009
SK15.04.2009
BG15.07.2009
SE15.07.2009
GR16.07.2009
IE09.09.2009
PT15.09.2009
CH30.09.2009
LI30.09.2009
MC30.09.2009
Former [2010/35]AT15.04.2009
BE15.04.2009
CZ15.04.2009
DK15.04.2009
EE15.04.2009
FI15.04.2009
NL15.04.2009
SK15.04.2009
BG15.07.2009
SE15.07.2009
IE09.09.2009
PT15.09.2009
MC30.09.2009
Former [2010/20]AT15.04.2009
BE15.04.2009
CZ15.04.2009
DK15.04.2009
EE15.04.2009
FI15.04.2009
NL15.04.2009
SK15.04.2009
BG15.07.2009
SE15.07.2009
PT15.09.2009
MC30.09.2009
Former [2010/18]AT15.04.2009
BE15.04.2009
CZ15.04.2009
DK15.04.2009
EE15.04.2009
FI15.04.2009
NL15.04.2009
SK15.04.2009
BG15.07.2009
SE15.07.2009
PT15.09.2009
Former [2010/10]AT15.04.2009
BE15.04.2009
CZ15.04.2009
DK15.04.2009
EE15.04.2009
FI15.04.2009
NL15.04.2009
SK15.04.2009
SE15.07.2009
PT15.09.2009
Former [2010/09]AT15.04.2009
CZ15.04.2009
DK15.04.2009
EE15.04.2009
FI15.04.2009
NL15.04.2009
SE15.07.2009
PT15.09.2009
Former [2010/08]AT15.04.2009
DK15.04.2009
EE15.04.2009
FI15.04.2009
NL15.04.2009
SE15.07.2009
PT15.09.2009
Former [2009/52]AT15.04.2009
FI15.04.2009
NL15.04.2009
SE15.07.2009
PT15.09.2009
Former [2009/50]AT15.04.2009
FI15.04.2009
NL15.04.2009
PT15.09.2009
Former [2009/49]AT15.04.2009
FI15.04.2009
PT15.09.2009
Documents cited:Search[X]  - HACK JASON B; LEVISS JOHN A; NELSON LEWIS S; HOFFMAN ROBERT S, "Severe symptoms following a massive intentional L-thyroxine ingestion", VETERINARY AND HUMAN TOXICOLOGY, (199910), vol. 41, no. 5, pages 323 - 326, XP008046262 [X] 1 * page 323, abstract *
 [X]  - COHEN J H III; INGBAR S H; BRAVERMAN L E, "THYROTOXICOSIS DUE TO INGESTION OF EXCESS THYROID HORMONE", ENDOCRINE REVIEWS, (1989), vol. 10, no. 2, pages 113 - 124, XP008046261 [X] 1 * page 122, column L, paragraph 1 *
 [X]  - MANDEL S H; MAGNUSSON A R; BURTON B T; SWANSON J R; LAFRANCHI S H, "Massive levothyroxine ingestion. Conservative management", CLINICAL PEDIATRICS, (198908), vol. 28, no. 8, pages 374 - 376, XP008046266 [X] 1 * page 374, column R, paragraph 2 *
 [Y]  - HERRMANN J; RUDORFF K H; GOCKENJAN G, KONIGSHAUSEN TH, GRABENSEE B, KRUSKEMPER H L, "Charcoal haemoperfusion in thyroid storm", THE LANCET, (1977), vol. 309, no. 8005, page 248, XP008046264 [Y] 1-3 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0140-6736(77)91034-0
 [Y]  - CANDRINA R; DI STEFANO O; SPANDRIO S; GIUSTINA G, "TREATMENT OF THYROTOXIC STORM BY CHARCOAL PLASMA PERFUSION", JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, (1989), vol. 12, no. 2, pages 133 - 134, XP008046263 [Y] 1-3 * page 133, column L, paragraph 1 *
 [Y]  - BINIMELIS J; BASSAS L; MARRUECOS L; RODRIGUEZ J; DOMINGO M L; MADOZ P; ARMENGOL S; MANGUES M A; DE LEIVA A, "Massive thyroxine intoxication: evaluation of plasma extraction", INTENSIVE CARE MEDICINE, (1987), vol. 13, no. 1, pages 33 - 38, XP008046260 [Y] 1-3 * page 34, column R, paragraph 2 *

DOI:   http://dx.doi.org/10.1007/BF00263555
International search[X]  - "Clinical progress of active carbon in treating hyperlipemia", XI BEI YAO XUE ZA ZHI, (199704), vol. 12, no. 2, page 91
 [X]  - "The application of active carbon microparticales (CH40) in cervical lymph node dissection for oral saquamous cell carcinoma", ZHONG GUO YI KE DA XUE XUE BAO, (199906), vol. 28, no. 3, pages 215 - 216
 [X]  - "Use of active carbon microparticales in treating carcinoma ventriculi", GUO WAI YI XUE ZHONG LIU XUE FEN CE, (199910), vol. 265, no. 5, pages 298 - 300
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.